Skip to main content
. 2016 Apr 11;4(2):136–140. doi: 10.1093/gastro/gow005

Table 3.

Insurance status of patients receiving colorectal cancer screening

Screening test Private Medicaid Medicare Other/unknown
Colonoscopy, n (%) 13 870 (66.0) 1670 (7.9) 1440 (6.9) 4030 (19.2)
Fecal occult blood testing, n (%) 4240 (43.5) 1160 (11.9) 750 (7.7) 3590 (36.9)
Flexible sigmoidoscopy, n (%) 340 (46.6) 50 (6.8) 70 (9.6) 270 (37.0)